Karen Tilmant

ktilmant@iu.edu
(812) 856-3957
IU Innovation Center, Room 230

Education
  • Universit√© de Lorraine, France, PhD, Toxicology, 2012
  • Avans University of Applied Sciences, Breda, Netherlands, Engineer degree, 2003
  • University of Ghent, Bachelor, 1995
Background
  • Investigative toxicologist, UCB Pharma, Belgium
Selected Publications

Tilmant K, Gerets H, De Ron P, Hanon E, Bento-Pereira C, Atienzar FA (2018). In vitro screening of cell bioenergetics to assess mitochondrial dysfunction in drug development. Toxicol In Vitro. 52:374-383.

Atienzar A, Delaunois A, Brouta F, ..., Tilmant K, Valentin JP (2016). Investigative safety strategies to improve success in drug development. J. Med. Dev. Sci., 2, 2:29

Tilmant K, Gerets HH, De Ron P, Cossu-Leguille C, Vasseur P, Dhalluin S, Atienzar FA (2013). The automated micronucleus assay for early assessment of genotoxicity in drug delopment. Mutat Res, 751(1):1-11.